SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-284626
Filing Date
2022-11-14
Accepted
2022-11-14 16:21:47
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382724d8k.htm   iXBRL 8-K 24585
2 EX-99.1 d382724dex991.htm EX-99.1 72428
6 GRAPHIC g382724icosavax.jpg GRAPHIC 10268
  Complete submission text file 0001193125-22-284626.txt   239344

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA icvx-20221114.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE icvx-20221114_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icvx-20221114_pre.xml EX-101.PRE 11703
8 EXTRACTED XBRL INSTANCE DOCUMENT d382724d8k_htm.xml XML 3458
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 221385892
SIC: 2836 Biological Products, (No Diagnostic Substances)